| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Fishman Robert P | EVP & Chief Financial Officer | 5500 WAYZATA BLVD., SUITE 900, GOLDEN VALLEY | /s/ John K. Wilson, Attorney-in-Fact for Robert P. Fishman | 18 Nov 2025 | 0001399744 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PNR | Common Shares | Options Exercise | $299,905 | +5,820 | +9.7% | $51.53 | 65,590 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Tax liability | $301,875 | -2,875 | -4.4% | $105.00 | 62,715 | 14 Nov 2025 | Direct | F1 |
| transaction | PNR | Common Shares | Options Exercise | $99,954 | +1,408 | +2.2% | $70.99 | 64,123 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Tax liability | $100,695 | -959 | -1.5% | $105.00 | 63,164 | 14 Nov 2025 | Direct | F1 |
| transaction | PNR | Common Shares | Options Exercise | $99,814 | +1,937 | +3.1% | $51.53 | 65,101 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $204,388 | -1,937 | -3% | $105.52 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $16,541 | +321 | +0.51% | $51.53 | 63,485 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $33,871 | -321 | -0.51% | $105.52 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $101,587 | +1,431 | +2.3% | $70.99 | 64,595 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $150,844 | -1,431 | -2.2% | $105.41 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $67,393 | +1,491 | +2.4% | $45.20 | 64,655 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $157,102 | -1,491 | -2.3% | $105.37 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $30,141 | +425 | +0.67% | $70.92 | 63,589 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $44,755 | -425 | -0.67% | $105.31 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $33,758 | +476 | +0.75% | $70.92 | 63,640 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $50,126 | -476 | -0.75% | $105.31 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $49,087 | +1,086 | +1.7% | $45.20 | 64,250 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $114,429 | -1,086 | -1.7% | $105.37 | 63,164 | 14 Nov 2025 | Direct | F2 |
| transaction | PNR | Common Shares | Options Exercise | $43,943 | +619 | +0.98% | $70.99 | 63,783 | 14 Nov 2025 | Direct | |
| transaction | PNR | Common Shares | Sale | $65,250 | -619 | -0.97% | $105.41 | 63,164 | 14 Nov 2025 | Direct | F2 |
| holding | PNR | Common Shares - Restricted Stock Units | 12,318 | 14 Nov 2025 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +5,820 | +26% | $0.000000 | 28,280 | 14 Nov 2025 | Common Shares | 5,820 | $51.53 | Direct | F4 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +1,408 | +7.2% | $0.000000 | 20,903 | 14 Nov 2025 | Common Shares | 1,408 | $70.99 | Direct | F4 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +1,937 | +7.9% | $0.000000 | 26,343 | 14 Nov 2025 | Common Shares | 1,937 | $51.53 | Direct | F4 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +321 | +1.2% | $0.000000 | 26,022 | 14 Nov 2025 | Common Shares | 321 | $51.53 | Direct | F4 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +1,431 | +7.9% | $0.000000 | 19,472 | 14 Nov 2025 | Common Shares | 1,431 | $70.99 | Direct | F4 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +1,491 | +5% | $0.000000 | 31,177 | 14 Nov 2025 | Common Shares | 1,491 | $45.20 | Direct | F5 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +425 | +2.4% | $0.000000 | 18,172 | 14 Nov 2025 | Common Shares | 425 | $70.92 | Direct | F5 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +476 | +2.8% | $0.000000 | 17,696 | 14 Nov 2025 | Common Shares | 476 | $70.92 | Direct | F5 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +1,086 | +3.7% | $0.000000 | 30,091 | 14 Nov 2025 | Common Shares | 1,086 | $45.20 | Direct | F5 |
| transaction | PNR | Employee Stock Option (right to buy) | Options Exercise | $0 | +619 | +3.4% | $0.000000 | 18,853 | 14 Nov 2025 | Common Shares | 619 | $70.99 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Shares swapped to cover the stock option exercise prices resulting from the stock option exercises. |
| F2 | The price in Column 4 is a weighted average price. The prices actually received ranged from $105.00 to $105.598. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. |
| F3 | End-of-period holdings include shares acquired under a dividend reinvestment plan in exempt transactions not required to be reported pursuant to Section 16(a). |
| F4 | This option is presently exercisable in full. |
| F5 | One-third of the stock options become exercisable on the first, second and third anniversary of the grant. |